# Batch 16 Partial-8 Multi-Module / Note / PDF Reaudit Report

Generated: `2026-06-23`  
Coverage: the same 30 confirmed-core records in flat master-list row order already opened by `Batch 16 partial-1`: `ASD-0517`, `ASD-0518`, `ASD-0519`, `ASD-0520`, `ASD-0521`, `ASD-0522`, `ASD-0523`, `ASD-0524`, `ASD-0525`, `ASD-0526`, `ASD-0528`, `ASD-0529`, `ASD-0530`, `ASD-0531`, `ASD-0535`, `ASD-0536`, `ASD-0537`, `ASD-0538`, `ASD-0539`, `ASD-0540`, `ASD-0541`, `ASD-0542`, `ASD-0543`, `ASD-0544`, `ASD-0545`, `ASD-0547`, `ASD-0548`, `ASD-0549`, `ASD-0552`, and `ASD-0553`.  
Mode: `Batch 16 partial-8`; this closeout again followed the plan-defined structure: one-paper read-only evidence agents on the remaining open queue, one independent `Classification-Reviewer` on the merged packet, one writeback-agent attempt on the frozen landing subset, downgraded direct note writeback by `Main Controller` after the writeback agent returned no file edits, and single-writer master/progress/report closeout.

## 1. 本次落地范围

- 本次在 `Batch 16 partial-7` 剩余的 `3` 篇 open records 中，再落地 `2` 篇：
  - `ASD-0544`
  - `ASD-0547`
- 本次继续保守挂起 `1` 篇：
  - `ASD-0531`

## 2. 结果概览

- newly landed notes updated in this partial: `2`
- master rows updated in this partial: `2`
- progress rows updated in this partial: `3`
- no local PDFs were newly archived in this partial
- this partial closes two source-limited / safety-visible records without forcing unsupported module expansion:
  - `ASD-0544` lands as conservative `07`
  - `ASD-0547` lands as conservative `04`

## 3. 本次新增落地记录

| ID | Final modules or bucket | PDF / source status | Closeout note |
|---|---|---|---|
| ASD-0544 | `07` | safety-visible closeout; DOI resolved to IEEE Xplore; official landing returned WAF challenge; no local PDF | the stable concrete object remains cancer biomarker discovery, so this is still a medical record rather than `01.04`; this round lands it conservatively at `07` while making the publisher-boundary safety skip explicit |
| ASD-0547 | `04` | safety-visible closeout; no local PDF; downstream SPIE page not safely accessible in this environment | the stable object remains pixelated metasurface / engineered nanostructure design, so the paper now closes conservatively at `04`; this round does not add `09` because no safely accessed evidence supports an independent engineering-system or process object |

## 4. Continue Conservative / Safety Queue 的 `1` 篇

| ID | Current hold reason | Current status |
|---|---|---|
| ASD-0531 | current safe pass recovered only title-level therapeutic-discovery signal; DOI route hit a non-safe `http` bioRxiv hop and the safe `https` landing returned `403`, so no fresh safe abstract / full-text support was recovered for the older `06;07` reading | keep conservative with explicit safety-skip visibility; if reopened later, do not strengthen `06` without safe first-hand object evidence |

## 5. 关键边界说明

`ASD-0544`  
这篇的核心不再是“能不能把它写成更强的 biomarker paper”，而是“在只拿到 title-level object signal 和 publisher-boundary block 的情况下，是否还能保守收口”。本轮 reviewer 的结论是可以：标题已经稳定给出 `cancer biomarker discovery` 这一具体医学对象，所以它不是 `01.04`，也不需要往 `06` 扩张；真正缺的是官方 abstract / full text 的可安全访问性，因此应以 `07` 的 conservative safety-visible closeout 落地。

`ASD-0547`  
这篇的边界压力仍然是 `04` vs `09`，而不是 `01.04`。本轮安全可见证据仍只稳定指向 `pixelated metasurface design` / `engineered nanostructure design` 本体；下游 SPIE 页面继续不可安全访问，因此不再继续追逐不安全路由，但现有 title / DOI boundary evidence 已足够把它收口为 source-limited `04`，同时明确不添加 `09`。

`ASD-0531`  
这篇本轮没有像 `ASD-0545` 那样拿到可安全引用的 abstract-level object evidence。相反，本轮新的可确认事实是 DOI 路由会经过 non-safe `http` bioRxiv hop，而安全 `https` landing 又返回 `403`。因此它必须显式转入 safety-visible open 状态，而不能继续伪装成普通 source-limited hold；但仅凭本轮 title-level therapeutic wording，也还不足以在不改 note / master 的前提下强行把旧的 `06;07` 收口掉。

## 6. Multi-Agent Audit Trace

- `Evidence-Agent-A/B/C`
  - were created successfully as session-native sub-agents with one-paper ownership:
    - `ASD-0531`
    - `ASD-0544`
    - `ASD-0547`
  - all three returned completion packets
  - all three were closed immediately after their packets returned
- `Classification-Reviewer`
  - reviewed the merged evidence only
  - supported landing `ASD-0544` as conservative `07`
  - supported landing `ASD-0547` as conservative `04`
  - kept `ASD-0531` conservative with explicit safety-skip visibility
  - was closed immediately after its completion packet returned
- `Writeback-Agent-1`
  - was launched with exclusive ownership of:
    - `Younis_2025_Cancer_Biomarker_LitReview_Agent.md`
    - `Lee_2026_Closed_Loop_Pixelated_Metasurface_Design.md`
  - returned a completion packet but no file edits
  - was closed immediately
- `Main Controller`
  - downgraded to direct writeback on the same frozen two-note ownership set only
  - updated the two landed notes with safety-visible/source-limited closeout wording
  - updated the master list for the two landed rows
  - refreshed the progress tracker for the two landed rows and the one remaining safety-open row
  - wrote this partial report

## 7. 本 partial 后的统计变化

- confirmed included-and-classified record count remains `451`
- current progress tracker reviewed-row count remains `373`
- current progress tracker `closed=yes`: `270 -> 272`
- current progress tracker `closed=no`: `103 -> 101`
- batch-16 cumulative landed count: `27 -> 29`
- batch-16 cumulative remaining conservative/open count: `3 -> 1`

## 8. Next Step

`Batch 16` 现在仍然不应跳到 `ASD-0554+`。  
下一步仍应只处理以下 `1` 篇 `closed=no` 队列，并继续保持 conservative / safety-visible discipline:

- `ASD-0531`
